nach oben

Seminars in Immunopathology

Erschienen in:

01.04.2008 | Review

Immunological mechanisms in glaucoma

verfasst von: F. Grus, D. Sun

Erschienen in: Seminars in Immunopathology | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

Glaucoma is one of the most frequent causes of blindness worldwide. The elevated intraocular pressure does not explain glaucoma in all patients but can be considered as a risk factor of the disease. There are some evidences that autoimmune mechanisms may be involved in this disorder. This review attempts to demonstrate the findings about autoimmune mechanisms in glaucoma patients. Consistent up- and down-regulations in the autoantibody profiles against ocular antigens are present in glaucoma patients. These changes in natural autoimmunity could be found in independent study populations and might be a promising tool for glaucoma detection.

Avrameas S (1991) Natural autoantibodies: from ‘horror autotoxicus’ to ‘gnothi seauton’. Immunol Today 12:154–159PubMed

Erlanger BF (1989) Some thoughts on the structural basis of internal imagery. Immunol Today 10:151–152PubMedCrossRef

Fernandez-Shaw C, Marina A, Cazorla P, Valdivieso F, Vazquez J (1997) Anti-brain spectrin immunoreactivity in Alzheimer’s disease: degradation of spectrin in an animal model of cholinergic degeneration. J Neuroimmunol 77:91–98PubMedCrossRef

Fisher J, Levkovitch-Verbin H, Schori H, Yoles E, Butovsky O, Kaye JF, Ben-Nun A, Schwartz M (2001) Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies. J Neurosci 21:136–142PubMed

George J, Gilburd B, Shoenfeld Y (1997) The emerging concept of pathogenic natural autoantibodies. Hum Antibodies 8:70–75PubMed

Graus YM, De Baets MH (1993) Myasthenia gravis: an autoimmune response against the acetylcholine receptor. Immunol Res 12:78–100PubMedCrossRef

Grus FH, Joachim SC, Bruns K, Lackner KJ, Pfeiffer N, Wax MB (2006) Serum autoantibodies to {alpha}-fodrin are present in glaucoma patients from Germany and the United States. Invest Ophthalmol Vis Sci 47:968–976PubMedCrossRef

Grus FH, Joachim SC, Hoffmann EM, Pfeiffer N (2004) Complex autoantibody repertoires in patients with glaucoma. Mol Vis 10:132–137PubMed

Grus FH, Joachim SC, Pfeiffer N (2003) Analysis of complex autoantibody repertoires by surface-enhanced laser desorption/ionization-time of flight mass spectrometry. Proteomics 3:957–961PubMedCrossRef

10.

Hughes BW, Moro De Casillas ML, Kaminski HJ (2004) Pathophysiology of myasthenia gravis. Semin Neurol 24:21–30PubMedCrossRef

11.

Ikeda Y, Maruyama I, Nakazawa M, Ohguro H (2002) Clinical significance of serum antibody against neuron-specific enolase in glaucoma patients. Jpn J Ophthalmol 46:13–17PubMedCrossRef

12.

Janicke RU, Ng P, Sprengart ML, Porter AG (1998) Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J Biol Chem 273:15540–15545PubMedCrossRef

13.

Joachim SC, Bruns K, Lackner KJ, Pfeiffer N, Grus FH (2007) Antibodies to alpha B-crystallin, vimentin, and heat shock protein 70 in aqueous humor of patients with normal tension glaucoma and IgG antibody patterns against retinal antigen in aqueous humor. Curr Eye Res 32:501–509PubMedCrossRef

14.

Joachim SC, Bruns K, Lackner KJ, Pfeiffer N, Grus FH (2007) Analysis of IgG antibody patterns against retinal antigens and antibodies to alpha-crystallin, GFAP, and alpha-enolase in sera of patients with “wet” age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 245:619–626PubMedCrossRef

15.

Joachim SC, Grus FH, Pfeiffer N (2003) Analysis of autoantibody repertoires in sera of patients with glaucoma. Eur J Ophthalmol 13:752–758PubMed

16.

Joachim SC, Kraft D, Pfeiffer N, Wax MB, Grus FH (2006) Antibody profile analysis via western blot and protein-chip methods in a retinal ganglion cell degeneration animal model. From Genome to Proteome Meeting

17.

Joachim SC, Pfeiffer N, Grus FH (2005) Autoantibodies in patients with glaucoma: a comparison of IgG serum antibodies against retinal, optic nerve, and optic nerve head antigens. Graefes Arch Clin Exp Ophthalmol 243:817–823PubMedCrossRef

18.

Joachim SC, Reichelt J, Pfeiffer N, Grus FH (2006) Autoantibody profiles against human retina in sera of glaucoma patients. DOG Meeting

19.

Joachim SC, Wuenschig D, Pfeiffer N, Grus FH (2007) IgG antibody patterns in aqueous humor of patients with primary open angle glaucoma and pseudoexfoliation glaucoma. Mol Vis 13:1573–1579PubMed

20.

Johnson EM Jr., Gorin PD, Osborne PA, Rydel RE, Pearson J (1982) Effects of autoimmune NGF deprivation in the adult rabbit and offspring. Brain Res 240:131–140PubMedCrossRef

21.

Kremmer S, Kreuzfelder E, Klein R, Bontke N, Henneberg-Quester KB, Steuhl KP, Grosse-Wilde H (2001) Antiphosphatidylserine antibodies are elevated in normal tension glaucoma. Clin Exp Immunol 125:211–215PubMedCrossRef

22.

Kulberg AY (1999) Immunoglobulins and Antibodies. Russ J Immunol 4:241–242PubMed

23.

Li WH, Zhao J, Li HY, Liu H, Li AL, Wang HX, Wang J, He K, Liang B, Yu M, Shen BF, Zhang XM (2006) Proteomics-based identification of autoantibodies in the sera of healthy Chinese individuals from Beijing. Proteomics 6:4781–4789PubMedCrossRef

24.

Maruyama I, Ohguro H, Ikeda Y (2000) Retinal ganglion cells recognized by serum autoantibody against gamma-enolase found in glaucoma patients. Invest Ophthalmol Vis Sci 41:1657–1665PubMed

25.

McKinnon SJ (2003) Glaucoma: ocular Alzheimer’s disease? Front Biosci 8:s1140–1156PubMedCrossRef

26.

Nobrega A, Haury M, Grandien A, Malanchere E, Sundblad A, Coutinho A (1993) Global analysis of antibody repertoires. II. Evidence for specificity, self-selection and the immunological “homunculus” of antibodies in normal serum. Eur J Immunol 23:2851–2859PubMedCrossRef

27.

Poletaev A, Osipenko L (2003) General network of natural autoantibodies as immunological homunculus (Immunculus). Autoimmun Rev 2:264–271PubMedCrossRef

28.

Poletaev AB, Abrosimova AA, Sokolov MA, Gekht AB, Alferova VV, Gusev EI, Nikolaeva TY, Selmi C (2004) Dialectics and implications of natural neurotropic autoantibodies in neurological disease and rehabilitation. Clin Dev Immunol 11:151–156PubMedCrossRef

29.

Poletaev AB, Gnedenko BB, Makarova AA, Krasnopolsky VI, Budykina TS, Petrukhin VA, Morozov SG (2000) Possible mechanisms of diabetic fetopathy. Hum Antibodies 9:189–197PubMed

30.

Poletaev AB, Morozov SG, Gnedenko BB, Zlunikin VM, Korzhenevskey DA (2000) Serum anti-S100b, anti-GFAP and anti-NGF autoantibodies of IgG class in healthy persons and patients with mental and neurological disorders. Autoimmunity 32:33–38PubMedCrossRef

31.

Quigley HA (1996) Number of people with glaucoma worldwide. Br J Ophthalmol 80:389–393PubMedCrossRef

32.

Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90:262–267PubMedCrossRef

33.

Reichelt J, Joachim SC, Pfeiffer N, Grus FH (2006) Analysis of autoantibodies against human retinal antigens in sera of patients with glaucoma and ocular hypertension. Graefes Arch Clin Exp Ophthalmol DOI 10.1007/s00417-007-0737-8

34.

Scofield RH (2004) Autoantibodies as predictors of disease. Lancet 363:1544–1546PubMedCrossRef

35.

Sihag RK, Cataldo AM (1996) Brain beta-spectrin is a component of senile plaques in Alzheimer’s disease. Brain Res 743:249–257PubMedCrossRef

36.

Singer HS, Loiselle CR, Lee O, Garvey MA, Grus FH (2003) Anti-basal ganglia antibody abnormalities in Sydenham chorea. J Neuroimmunol 136:154–161PubMedCrossRef

37.

Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt J, Singh K (1991) Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol 109:1090–1095PubMed

38.

Tahzib NG, Ransom NL, Reitsamer HA, McKinnon SJ (2004) Alpha-fodrin is cleaved by caspase-3 in a chronic ocular hypertensive (COH) rat model of glaucoma. Brain Res Bull 62:491–495PubMedCrossRef

39.

Terzoglou AG, Routsias JG, Avrameas S, Moutsopoulos HM, Tzioufas AG (2006) Preferential recognition of the phosphorylated major linear B-cell epitope of La/SSB 349–368 aa by anti-La/SSB autoantibodies from patients with systemic autoimmune diseases. Clin Exp Immunol 144:432–439PubMedCrossRef

40.

Tezel G, Wax MB (2004) The immune system and glaucoma. Curr Opin Ophthalmol 15:80–84PubMedCrossRef

41.

Tezel G, Wax MB (2007) Glaucoma. Chem Immunol Allergy 92:221–227PubMed

42.

Tezel G, Edward DP, Wax MB (1999) Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma. Arch Ophthalmol 117:917–924PubMed

43.

Tezel G, Hernandez R, Wax MB (2000) Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes. Arch Ophthalmol 118:511–518PubMed

44.

Tezel G, Luo C, Yang X (2007) Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head. Invest Ophthalmol Vis Sci 48:1201–1211PubMedCrossRef

45.

Tezel G, Seigel GM, Wax MB (1998) Autoantibodies to small heat shock proteins in glaucoma. Invest Ophthalmol Vis Sci 39:2277–2287PubMed

46.

Tezel G, Yang X, Cai J (2005) Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma. Invest Ophthalmol Vis Sci 46:3177–3187PubMedCrossRef

47.

Tezel G, Yang X, Luo C, Peng Y, Sun SL, Sun D (2007) Mechanisms of immune system activation in glaucoma: oxidative stress-stimulated antigen presentation by the retina and optic nerve head glia. Invest Ophthalmol Vis Sci 48:705–714PubMedCrossRef

48.

Vazquez J, Fernandez-Shaw C, Marina A, Haas C, Cacabelos R, Valdivieso F (1996) Antibodies to human brain spectrin in Alzheimer’s disease. J Neuroimmunol 68:39–44PubMedCrossRef

49.

Vincent A, McConville J, Farrugia ME, Newsom-Davis J (2004) Seronegative myasthenia gravis. Semin Neurol 24:125–133PubMedCrossRef

50.

Wax MB, Tezel G (2002) Neurobiology of glaucomatous optic neuropathy: diverse cellular events in neurodegeneration and neuroprotection. Mol Neurobiol 26:45–55PubMedCrossRef

51.

Wax MB, Barrett DA, Pestronk A (1994) Increased incidence of paraproteinemia and autoantibodies in patients with normal-pressure glaucoma. Am J Ophthalmol 117:561–568PubMed

52.

Wax MB, Tezel G, Saito I, Gupta RS, Harley JB, Li Z, Romano C (1998) Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal-pressure glaucoma. Am J Ophthalmol 125:145–157PubMedCrossRef

53.

Weinreb RN, Khaw PT (2004) Primary open-angle glaucoma. Lancet 363:1711–1720PubMedCrossRef

54.

Yang J, Tezel G, Patil RV, Romano C, Wax MB (2001) Serum autoantibody against glutathione S-transferase in patients with glaucoma. Invest Ophthalmol Vis Sci 42:1273–1276PubMed

55.

Zimmermann CW, Eblen F (1993) Repertoires of autoantibodies against homologous eye muscle in ocular and generalized myasthenia gravis differ. Clin Investig 71:445–451PubMedCrossRef

56.

Zimmermann CW, Weiss G (1987) Antibodies not directed against the acetylcholine receptor in myasthenia gravis. An immunoblot study. J Neuroimmunol 16:225–236PubMedCrossRef

Titel: Immunological mechanisms in glaucoma
verfasst von: F. Grus
D. Sun
Publikationsdatum: 01.04.2008
Verlag: Springer-Verlag
Erschienen in: Seminars in Immunopathology / Ausgabe 2/2008
Print ISSN: 1863-2297
Elektronische ISSN: 1863-2300
DOI: https://doi.org/10.1007/s00281-008-0105-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2008

The role of complement in ocular pathology

Angiogenesis in eye disease: immunity gained or immunity lost?

Autoimmune retinopathy: A review and summary

Immunological mechanisms in the pathogenesis of diabetic retinopathy

Immunopathology of the eye